V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10327921 | 10039679 | 1.67 | 66.3 | Curative (C) | 2019-08-06 | 2019-08-13 | Trial Unspecified | 02 | N | VENETOCLAX | 101410034 |
| 10327979 | 10039681 | null | null | null | 2022-04-01 | 2022-04-11 | DARATUMUMAB | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB | 101477670 |
| 10328110 | 10039683 | 1.72 | 65.6 | 03 | 2022-05-23 | 2022-05-26 | CARBOPLATIN + VINORELBINE | 02 | N | CARBOPLATIN + VINORELBINE | 100380096 |
| 10328154 | 10039684 | 1.84 | 64.7 | 03 | 2017-06-05 | 2017-06-08 | Cisplatin + Vinorelbine (PO) | N | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 100504596 |
| 10328293 | 10039689 | 1.7 | 64 | Palliative (P) | 2017-05-28 | 2017-06-22 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100552816 |
| 10328328 | 10039692 | 1.57 | 111.8 | Curative (C) | 2019-04-17 | 2019-04-17 | FLUOROURACIL | 02 | null | FLUOROURACIL | 100134591 |
| 10328332 | 10039693 | 1.69 | 83 | Palliative (P) | 2018-02-19 | 2018-02-24 | TEMOZOLOMIDE | 02 | N | TEMOZOLOMIDE | 100986131 |
| 10328406 | 10039695 | null | null | 03 | 2018-06-02 | 2018-06-16 | Folfirinox/ Folfoxiri | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101538234 |
| 10328408 | 10039696 | 1.62 | 78.8 | null | 2020-11-09 | 2020-11-09 | IPILIMUMAB + NIVOLUMAB | N | null | IPILIMUMAB + NIVOLUMAB | 100915082 |
| 10328449 | 10039698 | 1.69 | 77.7 | Curative (C) | 2018-09-02 | 2018-09-27 | CHLORAMBUCIL + RITUXIMAB | 2 | N | CHLORAMBUCIL + RITUXIMAB | 101688030 |
| 10328645 | 10039699 | null | null | Neo-adjuvant (N) | 2019-03-18 | 2019-04-18 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100877038 |
| 10328661 | 10039700 | 1.74 | 52 | null | 2020-12-06 | 2021-01-18 | Folfirinox/ Folfoxiri | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100581859 |
| 10328697 | 10039702 | 1.75 | 0 | null | 2022-02-28 | 2022-03-14 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | null | BCG | 101483330 |
| 10328707 | 10039703 | 1.74 | 90.6 | null | 2020-03-11 | 2020-03-16 | null | 02 | null | VENETOCLAX | 101501481 |
| 10328772 | 10039705 | 0 | 0 | 03 | 2019-03-16 | 2019-03-22 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100127333 |
| 10328776 | 10039706 | 1.7 | null | Adjuvant (A) | 2017-12-19 | 2018-01-09 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101580898 |
| 10328826 | 10039709 | 1.74 | 58 | null | 2018-09-16 | 2018-09-16 | Mitomycin Intravesical | 02 | null | MITOMYCIN INTRAVESICULAR | 101136660 |
| 10328926 | 10039710 | null | null | Adjuvant (A) | 2019-03-05 | 2019-03-05 | CHOP R | 02 | N | CHOP R | 100824891 |
| 10328964 | 10039711 | 1.65 | 51 | Curative (C) | 2019-01-02 | 2019-01-02 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100653050 |
| 10328996 | 10039713 | 1.8 | 64.8 | 03 | 2018-12-06 | 2019-01-04 | R Chlorambucil | 02 | N | CHLORAMBUCIL + RITUXIMAB | 100567676 |
| 10329035 | 10039714 | 1.52 | 90.7 | null | 2019-10-08 | 2019-10-08 | Temozolomide + RT | 02 | null | TEMOZOLOMIDE | 100904689 |
| 10329054 | 10039715 | 1.88 | null | Adjuvant (A) | 2017-08-04 | 2017-08-14 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | N | CYTARABINE | 101677244 |
| 10329109 | 10039716 | 1.64 | 66.6 | null | null | 2018-10-17 | Cladribine (subcut) 5 days | 02 | N | VENETOCLAX | 100280769 |
| 10329175 | 10039717 | 1.86 | 75.1 | Palliative (P) | 2019-06-05 | 2019-06-05 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | N | BUSULFAN | 100524645 |
| 10329233 | 10039718 | 1.44 | 94.4 | Disease modification (D) | 2017-11-24 | 2017-11-24 | null | 02 | N | SUNITINIB | 101723863 |
| 10329254 | 10039719 | 1.67 | 88 | null | 2019-05-28 | 2019-06-20 | CHOP - 21 days | 02 | null | VENETOCLAX | 100117649 |
| 10329307 | 10039720 | 1.72 | 78.7 | Palliative (P) | 2016-09-01 | 2016-09-03 | FEC 100 + DOCETAXEL | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 101852355 |
| 10329343 | 10039721 | 1.7 | 88.8 | 02 | 2019-01-31 | 2019-01-31 | Folfirinox | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101671591 |
| 10329384 | 10039722 | 1.71 | 85.8 | 03 | null | 2021-05-08 | Bortezomib +/- Dexamethasone | N | N | BORTEZOMIB | 101549727 |
| 10329420 | 10039723 | null | null | Curative (C) | 2019-07-02 | 2019-07-07 | EOX | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100516711 |
| 10329477 | 10039724 | 1.65 | 120 | Curative (C) | 2021-02-17 | 2021-02-22 | Temozolomide 200mg/m2 | 02 | null | TEMOZOLOMIDE | 100717850 |
| 10329594 | 10039726 | 0 | 0 | Adjuvant (A) | null | 2019-08-21 | Bortezomib + Thalidomide +/- Dex | N | N | BORTEZOMIB + THALIDOMIDE | 100539098 |
| 10329617 | 10039727 | 1.8 | 74.2 | null | 2018-08-23 | 2018-08-23 | CTD | 02 | null | DARATUMUMAB | 101503640 |
| 10329671 | 10039728 | 1.57 | 63 | null | 2021-07-15 | 2021-07-26 | Cladribine (subcut) 5 days | 02 | N | CYTARABINE | 100737814 |
| 10329677 | 10039729 | 0 | 0 | Disease modification (D) | 2020-03-14 | 2020-03-23 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100779626 |
| 10329717 | 10039730 | null | 95.5 | Palliative (P) | 2018-05-11 | 2018-05-11 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100948475 |
| 10329728 | 10039731 | 1.77 | 0 | null | null | 2022-01-22 | DABRAFENIB + TRAMETINIB | 02 | Y | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 101767960 |
| 10329739 | 10039733 | 1.86 | 60.4 | Curative (C) | 2018-07-21 | 2018-07-23 | Gemcitabine + Capecitabine | 02 | N | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 100954058 |
| 10329756 | 10039734 | 1.66 | 60 | null | 2018-07-20 | 2018-08-11 | Venetoclax | 02 | null | CISPLATIN + VINORELBINE | 101160073 |
| 10329818 | 10039736 | 1.41 | 66.2 | Curative (C) | 2016-03-30 | 2016-03-30 | Carboplatin + Vinorelbine Oral | 02 | N | CARBOPLATIN + VINORELBINE | 100538860 |
| 10329861 | 10039737 | 1.77 | 64 | Adjuvant (A) | null | 2017-06-09 | Palbociclib | 02 | N | PALBOCICLIB | 101073939 |
| 10329879 | 10039738 | null | null | null | 2019-02-18 | 2019-03-14 | MITOMYCIN | 2 | null | VENETOCLAX | 101177233 |
| 10329887 | 10039739 | 1.84 | 100.1 | Palliative (P) | 2017-07-21 | 2017-08-09 | FEC 60 or 75 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101419824 |
| 10330067 | 10039740 | 1.86 | 66.6 | 03 | 2016-03-26 | 2016-03-26 | CHLORAMBUCIL + RITUXIMAB | 02 | N | CHLORAMBUCIL + RITUXIMAB | 101592767 |
| 10330091 | 10039741 | null | null | Palliative (P) | 2019-08-06 | 2019-08-12 | Palbociclib | 02 | N | PALBOCICLIB | 100468186 |
| 10330099 | 10039742 | 0 | 70.4 | Curative (C) | 2016-12-18 | 2016-12-20 | null | 02 | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100198106 |
| 10330162 | 10039744 | 1.87 | 71.45 | null | 2018-11-29 | 2018-12-13 | Sunitinib | null | null | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100806888 |
| 10330177 | 10039745 | 0 | 71 | Curative (C) | null | 2019-12-19 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | N | VENETOCLAX | 101399793 |
| 10330280 | 10039747 | 1.68 | null | Curative (C) | 2017-10-20 | 2017-10-20 | null | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB | 101748324 |
| 10330281 | 10039748 | 1.82 | 69.8 | null | 2019-04-02 | 2019-04-10 | Venetoclax | 02 | null | BCG | 100778495 |